Thelma Therapeutics (XKRX:015540) Capital Expenditure : ₩-7,900.00 Mil (TTM As of Sep. 2022)

View and export this data going back to 1989. Start your Free Trial

What is Thelma Therapeutics Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Thelma Therapeutics's cash flow for capital expenditures for the three months ended in Sep. 2022 was ₩0 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Sep. 2022 was ₩-7,900.00 Mil.

Thelma Therapeutics Capital Expenditure Historical Data

The historical data trend for Thelma Therapeutics's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thelma Therapeutics Capital Expenditure Chart

Thelma Therapeutics Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Capital Expenditure

Get a 7-Day Free Trial

-882.68

-940.09

-1,129.77

-97.24

-7,906.93

Thelma Therapeutics Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Capital Expenditure	Get a 7-Day Free Trial															-1.21	-7,900.00	-	-	-

Thelma Therapeutics Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-7,900.00 Mil.

Thelma Therapeutics (XKRX:015540) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Thelma Therapeutics (XKRX:015540) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

N/A

Address

Mapo-gu, Seoul Sangam DMC Prugio City, 25, World Cup Buk-ro 54-gil, Seoul, KOR

Website

http://www.medi-plant.co.kr

Thelma Therapeutics, formerly Medipartner Biotechnology is a South Korean company engaged in providing hospital management support, dental material distribution, medical devices manufacturing, and development of new materials.

Thelma Therapeutics (XKRX:015540) Headlines

No Headlines